Waratah Capital Advisors’s Teladoc Health TDOC Stock Holding History

Waratah Capital Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,152	Closed	-$690K	–	297
2021 Q2	$690K	Buy	+4,152	New	+$673K	0.01%	166
2021 Q1	–	Sell	-4,531	Closed	-$906K	–	315
2020 Q4	$906K	Buy	+4,531	New	+$921K	0.06%	137

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Waratah Capital Advisors's TDOC Position: Q3 2021 in Review

Waratah Capital Advisors sold out of Teladoc Health (TDOC) in Q3 2021, closing a stake of 4,152 shares — an estimated $690K sold.

Waratah Capital Advisors first reported a position in TDOC in Q4 2020 and held it in 2 quarters. The position peaked at $906K in Q4 2020. 761 funds tracked by Wall St. Rank hold TDOC as of Q3 2021.

Waratah Capital Advisors reported no remaining Teladoc Health position as of Q3 2021 after selling out during the quarter.
Waratah Capital Advisors sold 4,152 Teladoc Health shares in Q3 2021, an estimated $690K.
Waratah Capital Advisors first reported a position in Teladoc Health in Q4 2020 and held it in 2 quarters.
Waratah Capital Advisors's Teladoc Health position peaked at $906K in Q4 2020.
761 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2021.

Based on Waratah Capital Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.